期刊
NUCLEIC ACID THERAPEUTICS
卷 26, 期 2, 页码 102-110出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/nat.2015.0580
关键词
-
资金
- MIUR grant, MERIT [RBNE08YFN3_001]
- MIUR grant, AIRC [13345]
- Italian Ministry of Economy and Finance
- Compagnia San Paolo [2011.1172]
- Italian Ministry of Health [GR-2011-02352546]
The Eph receptors are transmembrane proteins that belong to the receptor tyrosine kinases superfamily. Elevated Eph/ephrin expression levels have been associated with angiogenesis and tumor vasculature in many types of human cancers, including breast, lung, and prostate cancers, melanoma, and leukemia. In glioblastoma (GBM), the dysregulated expression of Eph receptors and of corresponding ephrin ligands has been associated with higher tumor grade and poor prognosis making them effective targets for therapeutic drugs. In this study, we describe the GL43.T, an anti-Eph aptamer, able to bind at high-affinity EphB3 and EphB2. Moreover, the GL43.T aptamer inhibits the glioma cell vitality and interferes with ephrine-B1 inhibition of chemotactic serum-stimulated cell migration. GL43.T aptamer represents a promising therapeutic molecule for EphB3-dependent cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据